ArticleACS chemical biology2026
High-Throughput Profiling of Prenylelongases Enables the Assembly of Modified Prenoids.
Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Modified (non-natural) prenoids are useful as chemical biology tools, designer fragrances, and building blocks of bioactive compounds. However, their laborious synthesis generally limits their widespread application. Although prenylelongases offer potential biocatalytic access to modified long-chain prenoids, these enzymes have remained underexplored since (i) they are difficult to assay in high throughput and (ii) their pyrophosphate substrates are challenging and expensive to synthesize. To address these gaps, we herein report how prenylelongases can be interrogated with continuous high-throughput assays using readily accessible monophosphates of their native and modified substrates, bypassing the need for laborious pyrophosphate synthesis. We demonstrate the utility of this assay platform for the biochemical characterization of a panel of diverse prenylelongases, their profiling with non-native substrates, and two exploratory engineering campaigns. Lastly, we demonstrate that wild-type PEs and their variants can be used to assemble modified prenoids selectively at the (semi)preparative scale. The methods and biochemical data herein will simplify the engineering of PEs toward expanded substrate scopes and facilitate biocatalytic access to modified prenoids and derivatives thereof.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.